查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405913

免疫測量市場規模、佔有率和趨勢分析報告：按產品、按技術、按應用、按檢體、按最終用途、按地區和細分市場預測，2024-2030 年

Immunoassay Market Size, Share & Trends Analysis Report By Product (Reagent & Kits, Analyzers/Instruments), By Technology (RIA, ELISA), By Application, By Specimen, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

免疫測量市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球免疫測量市場規模預計將達到 344.7 億美元。

預計2024年至2030年該市場將以3.60%的複合年成長率擴張。 PoC 快速測試和自動免疫測量分析儀的推出正在推動市場成長。此外，慢性病和感染疾病的增加導致市場快速成長。

據美國癌症協會稱，2020 年估計有 1690 萬癌症患者/倖存者。根據美國美國癌症研究所2019年的資料，美國約有180萬名癌症患者被診斷出來。根據美國癌症協會的數據，2019 年美國約有 606,880 人死於癌症。因此，癌症病例數量的增加正在推動對免疫測量的需求。預計這將推動未來幾年的市場成長。

此外，人們對感染疾病和預防措施的認知不斷提高，導致對快速診斷測試產品的需求旺盛，從而推動了銷售成長。根據世界衛生組織《2018 年世界瘧疾報告》的調查，製造商報告 2017 年側向流動試驗法的銷售額為 2.76 億份。另據報導，2017 年撒哈拉以南非洲約 75.0% 的瘧疾病例是透過側向流動試驗法診斷的。

一些基於智慧型手機的設備和相關工具正在成為下一代照護端診斷和測試設備，推動市場成長。例如，智慧型手機應用程式與自主毛細管微流控晶片相結合，已用於快速檢測心肌梗塞中的心肌肌鈣蛋白 I。該平台在資源有限的環境下易於使用，可在12分鐘內提供測試結果。因此，預計新的技術進步將在預測期內進一步推動市場。

西門子醫療有限公司於 2018 年 4 月宣佈在美國首次實施採用 Aptio 自動化的 Atellica免疫測量解決方案。該產品的目的是為了在美國普及先進的技術產品。 2020 年12 月，丹納赫旗下貝克曼庫爾特(Beckman Coulter) 宣布推出首個用於COVID-19 抗原檢測的高品質和高通量檢測方法，正式命名為Access SARS-CoV-2 抗原檢測方法。 2018 年 7 月，Cygnus Technologies 和 Gyros Protein Technologies 合作開發了免疫測量來識別生物治療毒素。兩家公司之間的策略聯盟將主要致力於提供生物分析解決方案和提高生物治療製造的效率。

免疫測量市場報告亮點

  • 酵素免疫測量（EIA）領域由於其在感染疾病和慢性病、食物過敏、藥物濫用等檢測中的重複使用，在2023年佔據了最大的市場佔有率，為63.39%。
  • 2023年，試劑和套件盒細分市場貢獻最大佔有率，達66.16%。龐大的市場佔有率歸因於由於感染疾病和自體免疫疾病的盛行率上升，對免疫測量測定試劑和診斷套件的需求不斷增加。
  • 從應用來看，傳染病檢查領域預計將在2023年佔據最大的市場佔有率，達到36.39%，並在預測期內以最快的複合年成長率成長。
  • 血液檢體細分市場佔比最大，2023年為43.11%。這是由於疾病發病率不斷增加，推動了對各種血液檢測程序的需求並支持了該領域的成長。
  • 按最終用途分類，醫院細分市場佔據主導地位，2023 年收益佔有率為 32.94%。醫院和診所是診斷和治療醫療狀況的初級保健機構。
  • 北美地區2023年收益最高，收益佔有率為40.60%。與慢性病相關的診斷需求的不斷成長以及技術先進的診斷技術的可用性的增加預計將在預測期內推動市場成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 慢性病和感染疾病的發生率增加
    • 即時診斷的需求增加
    • 對攜帶式和自動化免疫測量的需求不斷成長
  • 市場促進因素
    • 檢測下限值
    • 與免疫測量技術相關的局限性
  • 市場抑制因素分析
  • 營商環境分析
    • SWOT 分析；按因素（政治/法律、經濟/技術）
    • 波特五力分析
    • COVID-19感染疾病的影響分析

第4章 產品經營分析

  • 免疫測量市場：產品變異分析
  • 試劑和套件
    • 試劑和套件市場，2018-2030
    • ELISA 試劑和套件
    • 快速檢測試劑和套件
    • ELISPOT 試劑與套件
    • 蛋白質印跡試劑和套件
    • 其他試劑和套件
  • 分析儀/設備
    • 分析儀/儀器市場，2018-2030
    • 開放式系統
    • 封閉式系統
  • 軟體和服務
    • 軟體與服務市場，2018-2030

第5章檢體業務分析

  • 免疫測量市場：檢體變異分析
  • 血
  • 唾液
  • 尿
  • 其他

第6章技術商業分析

  • 免疫測量市場：技術變遷分析
  • 免疫測量
  • 酵素連結免疫測量快速檢測
    • 化學冷光免疫測量法
    • 螢光免疫測量法
  • 其他

第 7 章最終用途業務分析

  • 免疫測量市場：配銷通路波動分析
  • 醫院
  • 居家護理
  • 專科診所
  • 其他

第 8 章最終用途業務分析

  • 免疫測量市場：配銷通路波動分析
  • 醫院
  • 血庫
  • 臨床實驗室
  • 製藥和生物技術公司
  • 學術研究中心
  • 其他

第9章區域業務分析

  • 2023 年及 2030 年按地區分類的免疫測量市場佔有率
  • 北美洲
    • 北美免疫測量市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲免疫測量市場，2018-2030
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太免疫學分析市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲免疫測量市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • MEA 免疫分析市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章競爭形勢

  • 參與企業概況
  • 財務績效
  • 參與企業
    • 市場領導者
    • 2023 年免疫測量分析市場佔有率分析
    • 公司簡介
    • 策略規劃
Product Code: GVR-3-68038-066-8

Immunoassay Market Growth & Trends:

The global immunoassay market size is expected to reach USD 34.47 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.60% from 2024 to 2030. The introduction of PoC rapid tests and automated immunoassay analyzers is boosting market growth. In addition, the rising number of chronic and infectious diseases is leading to high market growth.

According to the American Cancer Society, there were an estimated 16.9 million cancer patients/survivors in 2020. Around 1.8 million cancer cases were diagnosed in the U.S., according to the National Cancer Institute 2019 data. According to the American Cancer Society, nearly 606,880 deaths occurred due to cancer in the U.S. in 2019. Thus, the rise in the number of cancer cases being diagnosed is driving the demand for immunoassays. This is expected to boost the market growth in the coming years.

Furthermore, growing awareness regarding infectious diseases and preventive measures has led to a high demand for rapid diagnostic test products, thereby increasing sales. Based on a survey by the WHO on the World malaria report 2018, manufacturers reported sales of 276 million for lateral flow assays in 2017. It also reported that around 75.0% of malaria cases were diagnosed using lateral flow assays in sub-Saharan Africa in 2017.

Several smartphone-based devices and associated tools have emerged as next-generation point-of-care diagnostics or testing devices, thereby boosting the market growth. For instance, a smartphone application combined with the autonomous capillary microfluidic chip is used for the rapid testing of cardiac troponin I in myocardial infarction. This platform can be easily used in resource-limited settings, providing test results within 12 minutes. Thus, novel technological advancements are anticipated to further drive the market over the forecast period.

The first implementation of the Atellica immunoassay solutions with Aptio automation in the United States was announced by Siemens Healthcare GmbH in April 2018. The objective of this product was designed to promote advanced technological products in the U.S. In December 2020, Beckman Coulter, a Danaher business, introduced its first high-quality as well as throughput assay for the COVID-19 antigen detection, officially named Access SARS-CoV-2 Antigen assay. In July 2018, Cygnus Technologies and Gyros Protein Technologies collaborated to produce immunoassay to identify biotherapeutic toxins. The two companies' strategic alliance will primarily focus on offering bioanalytical solutions and increasing biotherapeutics manufacturing efficiencies.

Immunoassay Market Report Highlights:

  • The enzyme immunoassays (EIA) segment held the largest market share of 63.39% in 2023, owing to their repeated usage in the detection of infectious and chronic diseases, food allergies, and drug abuse, among other applications.
  • The reagents and kits segment contributed to the largest share of 66.16% in 2023. A significant market share can be attributed to the increased demand for immunoassay reagents and diagnostic kits, owing to the rising prevalence of infectious and autoimmune diseases.
  • Based on application, the infectious diseases testing segment held the largest market share of 36.39% in 2023 and is anticipated to grow at the fastest CAGR over the forecast period.
  • The blood specimen segment held the largest share of 43.11% in 2023 attributed to an increase in disease occurrence, which drives demand for different blood testing procedures, supporting segment growth.
  • Based on end-use, the hospitals segment dominated the market in 2023 with a revenue share of 32.94%. Hospitals and clinics are primary care settings for the diagnosis and treatment of medical conditions.
  • North America generated the highest revenue in 2023 with a 40.60% revenue share. The rise in demand for diagnostics related to chronic diseases and the increase in availability of technologically advanced diagnostic techniques are expected to propel market growth over the forecast period.

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. Gvr's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Rising incidence of chronic and infectious diseases
    • 3.3.2. Increasing demand for point-of-care diagnostics
    • 3.3.3. Growing demand for portable and automated immunoassays
  • 3.4. Market Drivers
    • 3.4.1. Lower detection limit
    • 3.4.2. Limitations associated with immunoassay techniques
  • 3.5. Market Restraint Analysis
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Immunoassay market: Product Movement Analysis
  • 4.2. Reagents & Kits
    • 4.2.1. Reagents & Kits Market, 2018 - 2030 (USD Million)
    • 4.2.2. ELISA Reagents & Kits
      • 4.2.2.1. ELISA Reagents & Kits Market, 2018 - 2030 (USD Million)
    • 4.2.3. Rapid Test Reagents & Kits
      • 4.2.3.1. Rapid Test Reagents & Kits Market, 2018 - 2030 (USD Million)
    • 4.2.4. ELISPOT Reagents & Kits
      • 4.2.4.1. ELISPOT Reagents & Kits Market, 2018 - 2030 (USD Million)
    • 4.2.5. Western Blot Reagents & Kits
      • 4.2.5.1. Western Blot Reagents & Kits Market, 2018 - 2030 (USD Million)
    • 4.2.6. Other Reagents & Kits
      • 4.2.6.1. Other Reagents & Kits Market, 2018 - 2030 (USD Million)
  • 4.3. Analyzers/Instruments
    • 4.3.1. Analyzers/Instruments Market, 2018 - 2030 (USD Million)
    • 4.3.2. Open Ended Systems
      • 4.3.2.1. Open Ended Systems & Kits Market, 2018 - 2030 (USD Million)
    • 4.3.3. Close Ended Systems
      • 4.3.3.1. Close Ended Systems Reagents & Kits Market, 2018 - 2030 (USD Million)
  • 4.4. Software & Services
    • 4.4.1. Software & Services Market, 2018 - 2030 (USD Million)

Chapter 5. Specimen Business Analysis

  • 5.1. Immunoassay Market: Specimen Movement Analysis
  • 5.2. Blood
    • 5.2.1. Blood Market, 2018 - 2030 (USD Million)
  • 5.3. Saliva
    • 5.3.1. Saliva Market, 2018 - 2030 (USD Million)
  • 5.4. Urine
    • 5.4.1. Urine Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Technology Business Analysis

  • 6.1. Immunoassay Market: Technology Movement Analysis
  • 6.2. Radioimmunoassay
    • 6.2.1. Radioimmunoassay Market, 2018 - 2030 (USD Million)
  • 6.3. Enzyme Immunoassays Rapid Test
    • 6.3.1. Enzyme Immunoassays Rapid Test Market, 2018 - 2030 (USD Million)
    • 6.3.2. Chemiluminescence Immunoassays
      • 6.3.2.1. Chemilluminescence Immunoassays Market, 2018 - 2030 (USD Million)
    • 6.3.3. Fluroscence Immunoassays
      • 6.3.3.1. Fluroscence Immunoassays Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. End-use Business Analysis

  • 7.1. Immunoassay Market: Distribution Channel Movement Analysis
  • 7.2. Hospitals
    • 7.2.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 7.3. Homecare
    • 7.3.1. Homecare Market, 2018 - 2030 (USD Million)
  • 7.4. Specialty Clinics
    • 7.4.1. Specialty Clinics Market, 2018 - 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. End-use Business Analysis

  • 8.1. Immunoassay Market: Distribution Channel Movement Analysis
  • 8.2. Hospitals
    • 8.2.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 8.3. Blood Banks
    • 8.3.1. Blood Banks Market, 2018 - 2030 (USD Million)
  • 8.4. Clinical Laboratories
    • 8.4.1. Clinical Laboratories Market, 2018 - 2030 (USD Million)
  • 8.5. Pharmaceutical and Biotech Companies
    • 8.5.1. Pharmaceutical and Biotech Companies Market, 2018 - 2030 (USD Million)
  • 8.6. Academic Research Centers
    • 8.6.1. Academic Research Centers Market, 2018 - 2030 (USD Million)
  • 8.7. Others
    • 8.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Immunoassay Market Share By Region, 2023 & 2030
  • 9.2. North America
    • 9.2.1. North America Immunoassay market, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Target Disease Prevalence
      • 9.2.2.3. Competitive Scenario
      • 9.2.2.4. Regulatory Framework
      • 9.2.2.5. Reimbursement Scenario
      • 9.2.2.6. U.S. Immunoassay market, 2018 - 2030 (USD MILLION)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Target Disease Prevalence
      • 9.2.3.3. Competitive Scenario
      • 9.2.3.4. Regulatory Framework
      • 9.2.3.5. Reimbursement Scenario
      • 9.2.3.6. Canada Immunoassay market, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Immunoassay market, 2018 - 2030 (USD Million)
    • 9.3.2. Germany
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. Reimbursement Scenario
      • 9.3.2.6. Germany Immunoassay market, 2018 - 2030 (USD Million)
    • 9.3.3. UK
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Reimbursement Scenario
      • 9.3.3.6. UK Immunoassay market, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Reimbursement Scenario
      • 9.3.4.6. France Immunoassay market, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Target Disease Prevalence
      • 9.3.5.3. Competitive Scenario
      • 9.3.5.4. Regulatory Framework
      • 9.3.5.5. Reimbursement Scenario
      • 9.3.5.6. Italy Immunoassay market, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Target Disease Prevalence
      • 9.3.6.3. Competitive Scenario
      • 9.3.6.4. Regulatory Framework
      • 9.3.6.5. Reimbursement Scenario
      • 9.3.6.6. Spain Immunoassay market, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Target Disease Prevalence
      • 9.3.7.3. Competitive Scenario
      • 9.3.7.4. Regulatory Framework
      • 9.3.7.5. Reimbursement Scenario
      • 9.3.7.6. Denmark Immunoassay market, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Target Disease Prevalence
      • 9.3.8.3. Competitive Scenario
      • 9.3.8.4. Regulatory Framework
      • 9.3.8.5. Reimbursement Scenario
      • 9.3.8.6. Sweden Immunoassay market, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Target Disease Prevalence
      • 9.3.9.3. Competitive Scenario
      • 9.3.9.4. Regulatory Framework
      • 9.3.9.5. Reimbursement Scenario
      • 9.3.9.6. Norway Immunoassay market, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Immunoassay market, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. Reimbursement Scenario
      • 9.4.2.6. Japan Immunoassay market, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Reimbursement Scenario
      • 9.4.3.6. China Immunoassay market, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. Reimbursement Scenario
      • 9.4.4.6. India Immunoassay market, 2018 - 2030 (USD Million)
    • 9.4.5. South Korea
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Reimbursement Scenario
      • 9.4.5.6. South Korea Immunoassay market, 2018 - 2030 (USD Million)
    • 9.4.6. Australia
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Reimbursement Scenario
      • 9.4.6.6. Australia Immunoassay market, 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Reimbursement Scenario
      • 9.4.7.6. Thailand Immunoassay market, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Immunoassay market, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Reimbursement Scenario
      • 9.5.2.6. Brazil Immunoassay market, 2018 - 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Reimbursement Scenario
      • 9.5.3.6. Mexico Immunoassay market, 2018 - 2030 (USD Million)
    • 9.5.4. Argentina
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. Reimbursement Scenario
      • 9.5.4.6. Argentina Immunoassay market, 2018 - 2030 (USD Million)
  • 9.6. MEA
    • 9.6.1. MEA Immunoassay market, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Reimbursement Scenario
      • 9.6.2.6. South Africa Immunoassay market, 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Reimbursement Scenario
      • 9.6.3.6. Saudi Arabia Immunoassay market, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Target Disease Prevalence
      • 9.6.4.3. Competitive Scenario
      • 9.6.4.4. Regulatory Framework
      • 9.6.4.5. Reimbursement Scenario
      • 9.6.4.6. UAE Immunoassay market, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Target Disease Prevalence
      • 9.6.5.3. Competitive Scenario
      • 9.6.5.4. Regulatory Framework
      • 9.6.5.5. Reimbursement Scenario
      • 9.6.5.6. Kuwait Immunoassay market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant's overview
  • 10.2. Financial performance
  • 10.3. Participant categorization
    • 10.3.1. Market Leaders
    • 10.3.2. Immunoassay market Share Analysis, 2023
    • 10.3.3. Company Profiles
      • 10.3.3.1. Siemens Healthineers
      • 10.3.3.1.1. Company Overview
      • 10.3.3.1.2. Financial Performance
      • 10.3.3.1.3. Product Benchmarking
      • 10.3.3.1.4. Strategic Initiatives
      • 10.3.3.2. bioMerieux SA
      • 10.3.3.2.1. Company Overview
      • 10.3.3.2.2. Financial Performance
      • 10.3.3.2.3. Product Benchmarking
      • 10.3.3.2.4. Strategic Initiatives
      • 10.3.3.3. Abbott Laboratories
      • 10.3.3.3.1. Company Overview
      • 10.3.3.3.2. Financial Performance
      • 10.3.3.3.3. Product Benchmarking
      • 10.3.3.3.4. Strategic Initiatives
      • 10.3.3.4. Danaher Corporation (Beckman Coulter)
      • 10.3.3.4.1. Company Overview
      • 10.3.3.4.2. Financial Performance
      • 10.3.3.4.3. Product Benchmarking
      • 10.3.3.4.4. Strategic Initiatives
      • 10.3.3.5. Quidel Corporation
      • 10.3.3.5.1. Company Overview
      • 10.3.3.5.2. Financial Performance
      • 10.3.3.5.3. Product Benchmarking
      • 10.3.3.5.4. Strategic Initiatives
      • 10.3.3.6. Ortho Clinical Diagnostics
      • 10.3.3.6.1. Company Overview
      • 10.3.3.6.2. Financial Performance
      • 10.3.3.6.3. Product Benchmarking
      • 10.3.3.6.4. Sysmex Corporation
      • 10.3.3.7. Bio-Rad Laboratories, Inc.
      • 10.3.3.7.1. Company Overview
      • 10.3.3.7.2. Financial Performance
      • 10.3.3.7.3. Product Benchmarking
      • 10.3.3.7.4. Strategic Initiatives
      • 10.3.3.8. Becton, Dickinson, and Company
      • 10.3.3.8.1. Company Overview
      • 10.3.3.8.2. Financial Performance
      • 10.3.3.8.3. Product Benchmarking
      • 10.3.3.8.4. Strategic Initiatives
      • 10.3.3.9. F. Hoffmann-La Roche AG
      • 10.3.3.9.1. Company Overview
      • 10.3.3.9.2. Financial Performance
      • 10.3.3.9.3. Product Benchmarking
      • 10.3.3.9.4. Strategic Initiatives
      • 10.3.3.10. Thermo Fisher Scientific, Inc
      • 10.3.3.10.1. Company Overview
      • 10.3.3.10.2. Financial Performance
      • 10.3.3.10.3. Product Benchmarking
      • 10.3.3.10.4. Strategic Initiatives
      • 10.3.3.11. Sysmex Corporation
      • 10.3.3.11.1. Company Overview
      • 10.3.3.11.2. Financial Performance
      • 10.3.3.11.3. Product Benchmarking
      • 10.3.3.11.4. Strategic Initiatives
    • 10.3.4. Strategy Mapping
      • 10.3.4.1. Expansion
      • 10.3.4.2. Acquisition
      • 10.3.4.3. Collaborations
      • 10.3.4.4. Disease Type/Drug Class Launch
      • 10.3.4.5. Partnerships
      • 10.3.4.6. Others

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 Global Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 6 Global Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 7 Global Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 8 Global Immunoassays Market, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 North America Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 North America Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 North America Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 13 North America Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 14 North America Immunoassays Market, by Country, 2018 - 2030 (USD Million)
  • Table 15 U.S. Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 16 U.S. Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 17 U.S. Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 18 U.S. Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 19 U.S. Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 20 Canada Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 21 Canada Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 22 Canada Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 23 Canada Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 24 Canada Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 25 Europe Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 Europe Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 27 Europe Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 Europe Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 29 Europe Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 30 Europe Immunoassays Market, by Country, 2018 - 2030 (USD Million)
  • Table 31 Germany Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Germany Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Germany Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 34 Germany Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 35 Germany Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 36 UK Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 37 UK Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 38 UK Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 39 UK Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 40 UK Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 41 France Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 France Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 43 France Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44 France Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 45 France Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 46 Spain Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 Spain Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 48 Spain Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 49 Spain Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 50 Spain Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 51 Italy Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Italy Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 53 Italy Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 54 Italy Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 55 Italy Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 56 Denmark Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 57 Denmark Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 58 Denmark Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 59 Denmark Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 60 Denmark Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 61 Sweden Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 62 Sweden Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 63 Sweden Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 64 Sweden Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 65 Sweden Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 66 Norway Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 Norway Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 68 Norway Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 69 Norway Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 70 Norway Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Immunoassays Market, by Country, 2018 - 2030 (USD Million)
  • Table 77 South Korea Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 78 South Korea Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 79 South Korea Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 80 South Korea Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 81 South Korea Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 82 Thailand Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 83 Thailand Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 84 Thailand Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 Thailand Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 86 Thailand Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 87 Australia Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 88 Australia Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 89 Australia Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 90 Australia Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 91 Australia Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 92 China Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 93 China Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 94 China Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 China Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 96 China Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 97 Japan Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 98 Japan Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 99 Japan Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 100 Japan Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 101 Japan Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 102 India Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 103 India Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 104 India Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 105 India Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 106 India Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 107 Latin America Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 108 Latin America Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 109 Latin America Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 110 Latin America Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 111 Latin America Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 112 Latin America Immunoassays Market, by Country, 2018 - 2030 (USD Million)
  • Table 113 Brazil Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 114 Brazil Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 115 Brazil Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 116 Brazil Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 117 Brazil Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 118 Mexico Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 119 Mexico Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 120 Mexico Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 121 Mexico Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 122 Mexico Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 123 Argentina Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 124 Argentina Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 125 Argentina Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 126 Argentina Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 127 Argentina Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa Immunoassays Market, by Country, 2018 - 2030 (USD Million)
  • Table 134 South Africa Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 135 South Africa Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 136 South Africa Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 137 South Africa Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 138 South Africa Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 144 UAE Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 145 UAE Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 146 UAE Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 147 UAE Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 148 UAE Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 151 Kuwait Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 153 Kuwait Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Immunoassays Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration Vs Growth Prospect Mapping, 2023
  • Fig. 15 Regional Marketplace: Key Takeaways
  • Fig. 16 Regional Outlook, 2023 & 2030
  • Fig. 17 North America Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 18 U.S. Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 19 Canada Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 20 Europe Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 21 Germany Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 22 UK Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 23 France Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 24 Spain Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 25 Italy Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 26 Russia Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 27 Asia Pacific Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 28 Japan Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 29 China Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 30 India Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 31 Australia Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 32 South Korea Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 33 Singapore Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 34 Latin America Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 35 Brazil Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 37 Argentina Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 38 Middle East and Africa Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 39 South Africa Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 40 Saudi Arabia Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 41 UAE Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 42 Global Immunoassays Market, for, Reagents & Kits 2018 - 2030 (USD Million)
  • Fig. 43 Global Immunoassays Market, for, ELISA Reagents & Kits 2018 - 2030 (USD Million)
  • Fig. 44 Global Immunoassays Market, for, Rapid Test Reagents & Kits 2018 - 2030 (USD Million)
  • Fig. 45 Global Immunoassays Market, for, ELISPOT Reagents & Kits 2018 - 2030 (USD Million)
  • Fig. 46 Global Immunoassays Market, for, Western Blot Reagents & Kits 2018 - 2030 (USD Million)
  • Fig. 47 Global Immunoassays Market, for, Other Reagents & Kits 2018 - 2030 (USD Million)
  • Fig. 48 Global Immunoassays Market, for, Analyzers/Instruments 2018 - 2030 (USD Million)
  • Fig. 49 Global Immunoassays Market, for, Open-ended Systems 2018 - 2030 (USD Million)
  • Fig. 50 Global Immunoassays Market, for, Closed-ended Systems 2018 - 2030 (USD Million)
  • Fig. 51 Global Immunoassays Market, for, Software & Services 2018 - 2030 (USD Million)
  • Fig. 52 Global Immunoassays Market, for, Radioimmunoassay (RIA) 2018 - 2030 (USD Million)
  • Fig. 53 Global Immunoassays Market, for, Enzyme Immunoassays (EIA) 2018 - 2030 (USD Million)
  • Fig. 54 Global Immunoassays Market, for, Chemiluminescence Immunoassays (CLIA) 2018 - 2030 (USD Million)
  • Fig. 55 Global Immunoassays Market, for, Fluorescence Immunoassays (FIA) 2018 - 2030 (USD Million)
  • Fig. 56 Global Immunoassays Market, for, Rapid Test2018 - 2030 (USD Million)
  • Fig. 57 Global Immunoassays Market, for, Others 2018 - 2030 (USD Million)
  • Fig. 58 Global Immunoassays Market, for, Therapeutic Drug Monitoring2018 - 2030 (USD Million)
  • Fig. 59 Global Immunoassays Market, for, Oncology2018 - 2030 (USD Million)
  • Fig. 60 Global Immunoassays Market, for, Cardiology2018 - 2030 (USD Million)
  • Fig. 61 Global Immunoassays Market, for, Endocrinology2018 - 2030 (USD Million)
  • Fig. 62 Global Immunoassays Market, for, Infectious Disease Testing2018 - 2030 (USD Million)
  • Fig. 63 Global Immunoassays Market, for, Autoimmune Diseases 2018 - 2030 (USD Million)
  • Fig. 64 Global Immunoassays Market, for, Others 2018 - 2030 (USD Million)
  • Fig. 65 Global Immunoassays Market, for, Blood 2018 - 2030 (USD Million)
  • Fig. 66 Global Immunoassays Market, for, Saliva 2018 - 2030 (USD Million)
  • Fig. 67 Global Immunoassays Market, for, Urine 2018 - 2030 (USD Million)
  • Fig. 68 Global Immunoassays Market, for, Other Specimens 2018 - 2030 (USD Million)
  • Fig. 69 Global Immunoassays Market, for, Hospitals 2018 - 2030 (USD Million)
  • Fig. 70 Global Immunoassays Market, for, Blood Banks 2018 - 2030 (USD Million)
  • Fig. 71 Global Immunoassays Market, for, Clinical Laboratories 2018 - 2030 (USD Million)
  • Fig. 72 Global Immunoassays Market, for, Pharmaceutical and Biotech Companies 2018 - 2030 (USD Million)
  • Fig. 73 Global Immunoassays Market, for, Academic Research Centers 2018 - 2030 (USD Million)
  • Fig. 74 Global Immunoassays Market, for, Others 2018 - 2030 (USD Million)